Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NSFL1 cofactor p47, encoded by the NSFL1C gene, is a UBX domain-containing adaptor protein known for modulating the activity of the AAA ATPase valosin-containing protein (p97/VCP) by reducing its ATPase activity. It is essential for p97-mediated membrane fusion events, particularly in the fragmentation and reassembly of the Golgi apparatus during mitosis. NSFL1C also plays roles in regulating the localization of Aurora kinase A at the centrosome during cell division and spindle orientation, and may participate in transitional endoplasmic reticulum (tER) formation. Diseases associated with NSFL1C dysfunction include inclusion body myopathy with Paget disease of bone and frontotemporal dementia, and multisystem proteinopathy[1][2][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NSFL1 cofactor p47 (NSFL1C).